Manufacturer
Nuvaila
- Products listed
- 7
- Molecules
- 3
- Therapy areas
- 2
Nuvaila is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 7 of its products across 3 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Nuvaila Limited
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Nuvaila products through licensed channels, with the documents your regulator needs.
Immunology and transplant
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Amjevita 20 mg/0.2 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Amjevita 40 mg/0.4 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Amjevita 80 mg/0.8 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Wezlana 130 mg/26 mL injectionIntravenous Cold chain | Ustekinumab | US FDA | Available on request |
| Wezlana 45 mg/0.5 mL injectionSubcutaneous Cold chain | Ustekinumab | US FDA | Available on request |
| Wezlana 90 mg/1 mL injectionSubcutaneous Cold chain | Ustekinumab | US FDA | Available on request |
Gastroenterology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Mesalamine 1.2 g delayed-release tabletOralGeneric name | Mesalamine | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Nuvaila
Send a request for any of these products. We confirm the licensed source, documents and lead time.